Cardiovascular Research Center, Avicenna Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Clin Biochem. 2011 Dec;44(17-18):1390-5. doi: 10.1016/j.clinbiochem.2011.09.011. Epub 2011 Oct 2.
To investigate the association between serum antibody titers to Hsp27 (anti-Hsp27) and pro-oxidant-antioxidant balance (PAB) in patients with angiographically-defined coronary artery disease (CAD) with or without the metabolic syndrome (MS).
Subjects (n=243) were classified into MS+ (n=161) and MS- (n=82) subgroups, based on the AHA/NHBLI criteria.
Serum anti-Hsp27 titers were found to be significantly higher in the MS+ vs. MS- group. However, no significant difference was observed in serum PAB values. When assessed for individual components of MS, increased serum anti-Hsp27 was found to be higher in subgroups with elevated triglycerides, elevated blood pressure and reduced high-density lipoprotein cholesterol (HDL-C). Subgroups of patients with elevated triglycerides had higher PAB values. HDL-C was the only significant predictor of anti-Hsp27 in the population as a whole.
The evidence from this investigation indicates the presence of elevated anti-Hsp27 in patients with concurrent CAD and MS compared to those with CAD alone.
研究血管造影定义的冠心病(CAD)患者血清热休克蛋白 27 抗体(抗-Hsp27)与促氧化剂-抗氧化剂平衡(PAB)之间的关系,以及是否伴有代谢综合征(MS)。
根据 AHA/NHBLI 标准,将受试者(n=243)分为 MS+(n=161)和 MS-(n=82)亚组。
与 MS-组相比,MS+组血清抗-Hsp27 滴度明显升高。然而,血清 PAB 值没有显著差异。在评估 MS 的各个成分时,发现伴有甘油三酯升高、血压升高和高密度脂蛋白胆固醇(HDL-C)降低的亚组血清抗-Hsp27 升高。甘油三酯升高的亚组 PAB 值较高。HDL-C 是整个人群抗-Hsp27 的唯一显著预测因子。
本研究结果表明,与单纯 CAD 患者相比,同时患有 CAD 和 MS 的患者血清中存在抗-Hsp27 水平升高。